Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial
2014 · The Lancet Oncology · 279 citations
https://doi.org/10.1016/s1470-2045(14)70227-x